Your browser doesn't support javascript.
loading
Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects.
Frost, Charles; Shenker, Andrew; Jhee, Stanford; Yu, Zhigang; Wang, Jessie; Bragat, Alexander; Pursley, Janice; LaCreta, Frank.
Afiliação
  • Frost C; Exploratory Clinical and Translational Research, Bristol-Myers Squibb, Princeton, NJ, USA, charles.frost@bms.com.
  • Shenker A; Exploratory Clinical and Translational Research, Bristol-Myers Squibb, Princeton, NJ, USA, charles.frost@bms.com.
  • Jhee S; PAREXEL International Early Phase, Glendale, CA, USA.
  • Yu Z; Exploratory Clinical and Translational Research, Bristol-Myers Squibb, Princeton, NJ, USA, charles.frost@bms.com.
  • Wang J; Exploratory Development Global Biometric Sciences, Bristol-Myers Squibb, Princeton, NJ, USA.
  • Bragat A; Exploratory Clinical and Translational Research, Bristol-Myers Squibb, Princeton, NJ, USA, charles.frost@bms.com.
  • Pursley J; Analytical and Bioanalytical Development, Bristol Myers Squibb, Princeton, NJ, USA.
  • LaCreta F; Exploratory Clinical and Translational Research, Bristol-Myers Squibb, Princeton, NJ, USA, charles.frost@bms.com.
Clin Pharmacol ; 10: 153-163, 2018.
Article em En | MEDLINE | ID: mdl-30498375

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2018 Tipo de documento: Article